Should prescriptions travel borders? - A renewed look at drug re-importation



    HALIFAX, Sept. 20 /CNW/ - The United States cannot solve its "Medicare
donut hole" through Canada's back door. That's the conclusion of a new health
care paper published by the Atlantic Institute for Market Studies (AIMS). It
points out that as Americans head into an election year, drug re-importation
will likely become an issue, particularly with several states actively
promoting the re-importation of prescription drugs from Canada as a method to
control Medicare costs.
    "We should be concerned when American politicians start using
re-importation of Canadian drugs as a political smokescreen. A policy of
controlling US drug costs by shipping drugs north to Canada and hoping that
they will still be cheap when they come back into the United States is on a
par with asking the tooth fairy to provide a national dental service on the
grounds that it will be self-financing," writes author Brian Ferguson, AIMS
Fellow in Health Care Economics and a professor of economics at the University
of Guelph.

    To read the complete report, visit www.aims.ca or the detailed release at
www.aims.ca/mediareleases.asp?typeID=5&id=1887&fd=0&p=1




For further information:

For further information: Barbara Pike, AIMS Director of Communications,
(902) 429-1143, (902) 452-1172

Organization Profile

ATLANTIC INSTITUTE FOR MARKET STUDIES

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890